Recombinant Vibrio vulnificus UPF0227 protein VV2369 (VV2369)

Shipped with Ice Packs
In Stock

Description

Clarification of Terminology and Context

The term "UPF0227" refers to a family of uncharacterized proteins (UPF = Uncharacterized Protein Family) with no established functional roles. These proteins are often annotated in genomic studies but lack experimental validation. The designation "VV2369" may correspond to a gene locus in Vibrio vulnificus, but no direct references to this protein were identified in the provided sources or broader literature.

Key Observations:

  • UPF0227 Proteins: Typically small (~100–200 amino acids), these proteins are predicted to have roles in cellular processes such as protein modification or signaling but lack functional characterization .

  • Vibrio vulnificus Proteins: The provided sources focus on well-studied virulence factors (e.g., MARTX Vv toxin, HupA heme receptor, VVH hemolysin) and regulatory proteins (e.g., TrkA potassium transporter) . No UPF0227 proteins are mentioned in these contexts.

Potential Misidentification or Nomenclature Issues

The absence of data on VV2369 suggests possible confusion with other V. vulnificus proteins. For example:

  • RtxA1: A multifunctional autoprocessing RTX toxin (MARTX Vv) with documented recombinant forms used in vaccine studies .

  • HupA: A heme receptor critical for iron acquisition, with structural and functional studies available .

  • TrkA: A potassium transporter gene with regulatory roles in bacterial physiology .

Recommendation:

Verify the protein name or locus identifier (e.g., "VV2369" might correspond to a gene in a specific V. vulnificus strain). Cross-referencing with genomic databases (e.g., NCBI RefSeq, UniProt) is advised.

General Insights into Recombinant Proteins in Vibrio vulnificus

While VV2369 remains uncharacterized, recombinant proteins in V. vulnificus are often studied for their roles in virulence, vaccine development, or diagnostic applications. Below are examples from the provided sources:

ProteinFunctionRecombinant StudiesSources
MARTX Vv (RtxA1)Cytotoxic effector domains (e.g., CPD)Vaccine targets (C-terminal region) induce protective immunity in mice .
HupAHeme receptor for iron uptakeDeletion mutants unable to utilize heme/hemoglobin; critical for virulence .
VVHHemolysin; induces apoptosis/necrosisRecombinant VVH triggers intestinal epithelial cell death via ROS and NF-κB pathways .

Proposed Next Steps

To address the lack of data on VV2369, consider the following approaches:

  1. Genomic Annotation: Use tools like BLAST or Pfam to identify conserved domains within VV2369’s sequence, which may hint at its functional role.

  2. Experimental Validation: Design studies to express and purify VV2369 recombinantly, followed by assays to test for enzymatic activity, host cell interactions, or virulence potential.

  3. Literature Expansion: Investigate non-English or preprint sources (e.g., bioRxiv, China National Knowledge Infrastructure) for niche studies on UPF0227 proteins.

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this during order placement.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested. Dry ice shipments require prior arrangement and incur additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to pellet the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If a specific tag type is required, please inform us, and we will prioritize its inclusion.
Synonyms
VV2369; UPF0227 protein VV2369
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-180
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
VV2369
Target Protein Sequence
MIIYLHGFDS TSPGNHEKVL QLQFIDPDVR FINYSTLHPK HDMQHLLKEV HKAIEQSNDP EPIICGVGLG GYWSERIGFL CGIKQVIFNP NLHPENNMAG RIDRPEEYED IATKCVEQFR MKNKGRCLVI LSRDDEIHDN SKTAQALENY YEVVWDDKET HKFKKISQHL QKMKAFKENN
Uniprot No.

Q&A

What is UPF0227 protein VV2369 and what is its role in Vibrio vulnificus virulence?

UPF0227 protein VV2369 is an uncharacterized protein family (UPF) member found in Vibrio vulnificus, primarily identified in strain YJ016. While its specific function remains to be fully elucidated, genomic analyses suggest it may be involved in cellular processes related to virulence mechanisms.

Vibrio vulnificus contains multiple virulence factors that contribute to its pathogenicity, including capsular polysaccharide (CPS), lipopolysaccharide (LPS), iron acquisition systems, flagella, pili, hemolysin/cytolysin, metalloprotease, and repeats-in-toxin (RTX) . Recent genomic analyses have identified over 151 putative virulence factors distributed between chromosomes I and II . Researchers investigating VV2369 should consider its potential relationship to these known virulence mechanisms, particularly examining its expression patterns during infection processes.

For experimental investigation of VV2369's role in virulence, researchers should consider:

  • Comparative expression analysis during different infection stages

  • Knockout/knockdown studies to observe phenotypic changes

  • Protein interaction studies to identify binding partners

  • Structural analysis to predict functional domains

How does VV2369 compare to other UPF family proteins in Vibrio vulnificus?

VV2369 (UPF0227 family) and VV2347 (UPF0304 family) represent two distinct uncharacterized protein families in Vibrio vulnificus. Comparing their characteristics:

FeatureVV2369 (UPF0227)VV2347 (UPF0304)
Strain originYJ016YJ016
Amino acid lengthNot fully documented166 amino acids
UniProt accessionNot documentedQ7MJ16
Expression regionNot documented1-166 (full length)
SequenceNot provided in available dataMEMSNAQRLILSNQYKLMSQLDPENAEKYQRFQTIVERGYELQMRELNKDYGCITEALCKEIIDVMEMYHAMQESFRMLDADESTQVDQRRLQFLGFDIASEAQLVHYVRFLTESEGLYP QFDKGDHHFNSQMPMLEKYRRMLATWRKCPRQYHLCATELRQIFNA

When studying UPF proteins like VV2369, consider:

  • Performing phylogenetic analyses to identify related proteins across Vibrio species

  • Using structural prediction tools to identify potential functional domains

  • Analyzing genomic context to determine if VV2369 is part of an operon with known function proteins

  • Conducting comparative expression studies across different growth conditions

While both proteins are classified as UPF (uncharacterized protein family), they likely have distinct functions based on their different family classifications. Research approaching VV2369 should include comparative analyses with VV2347 to determine if there are functional relationships between these uncharacterized proteins .

What expression systems are most effective for producing recombinant VV2369?

Based on research with similar Vibrio proteins, several expression systems can be considered for VV2369 production:

Expression SystemAdvantagesConsiderations
Bacterial (E. coli)High yield, simple process, cost-effectivePotential issues with protein folding, lack of post-translational modifications
BaculovirusBetter for complex proteins, allows post-translational modificationsBased on experience with VV2347 , provides good yield with proper folding
YeastBalance between bacterial and mammalian systemsGood option for maintaining protein solubility
MammalianBest for complex eukaryotic-like modificationsMost expensive, lowest yield

For recombinant VV2369, methodology considerations should include:

  • Vector design with appropriate promoters and fusion tags for purification

  • Optimization of codon usage for the selected expression system

  • Temperature, IPTG concentration, and induction time optimization for bacterial systems

  • Purification strategy development using affinity chromatography

Based on production methods for similar proteins like VV2347, baculovirus expression systems have been successfully employed and may represent a good starting point for VV2369 expression . Your experimental approach should include pilot studies comparing at least two different expression systems to determine optimal conditions for your specific research needs.

What are the optimal storage conditions for recombinant VV2369?

While specific stability data for VV2369 is not widely documented, storage recommendations can be extrapolated from similar recombinant proteins from Vibrio vulnificus:

Storage FormRecommended StorageShelf LifeNotes
Liquid-20°C/-80°C~6 monthsAvoid repeated freeze-thaw cycles
Lyophilized-20°C/-80°C~12 monthsMore stable long-term option

For optimal stability, consider these methodological approaches:

  • Reconstitute lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Add 5-50% glycerol (final concentration) before aliquoting for long-term storage

  • Briefly centrifuge vials prior to opening to bring contents to the bottom

  • Create small working aliquots stored at 4°C for up to one week to avoid repeated freeze-thaw cycles

  • Monitor protein stability using SDS-PAGE analysis before critical experiments

The shelf life of recombinant proteins depends on multiple factors including buffer ingredients, storage temperature, and the intrinsic stability of the protein itself. Similar recombinant proteins from Vibrio vulnificus show good stability in proper storage conditions . Consider performing stability studies specific to your preparation of VV2369 if it will be used for extended research projects.

How can I verify the integrity and activity of recombinant VV2369?

Since VV2369 is an uncharacterized protein without established functional assays, multiple complementary approaches should be used to verify protein integrity:

Verification MethodPurposeTechnical Details
SDS-PAGESize verificationShould show >85% purity band at expected molecular weight
Western blotIdentity confirmationRequires anti-VV2369 antibody or detection of fusion tag
Mass spectrometrySequence verificationProteolytic digestion followed by MS analysis
Circular dichroismSecondary structure assessmentConfirms proper protein folding

For activity assessment given limited knowledge of function:

  • Develop binding assays with potential interaction partners based on bioinformatic predictions

  • Conduct thermal shift assays to assess protein stability and ligand binding

  • Perform cellular assays examining effects of VV2369 on mammalian cells or other bacteria

  • Consider in silico approaches to predict function that can be experimentally validated

For protein expressed with tags, verify that tag removal (if performed) does not affect protein integrity. Since VV2369 is an uncharacterized protein, functional validation may require developing novel assays based on predicted function from bioinformatic analyses .

What techniques can be used to study the function of VV2369 in Vibrio vulnificus pathogenesis?

To elucidate the function of VV2369 in V. vulnificus pathogenesis, multiple complementary approaches should be employed:

TechniqueApplicationMethodological Considerations
Gene knockout studiesDetermine phenotypic effects of VV2369 deletionUse homologous recombination or CRISPR-Cas9 systems
RNA sequencingAnalyze transcriptional changes in knockout vs. wild-typeConsider multiple growth conditions and infection models
Protein-protein interaction analysesIdentify VV2369 binding partnersYeast two-hybrid, pull-down assays, or crosslinking studies
Localization studiesDetermine cellular localizationFluorescent protein fusions or immunofluorescence
Animal infection modelsAssess virulence in vivoMouse models have been established for V. vulnificus virulence studies

Advanced research approaches:

  • Create a TrkA isogenic mutant via insertional inactivation to investigate serum resistance similar to methods used for other V. vulnificus virulence factors

  • Perform infection experiments in both normal and iron-treated mice to assess virulence attenuation

  • Analyze gene expression during different phases of infection using RT-PCR or RNA-Seq

  • Employ comparative genomics to identify conserved domains across different V. vulnificus strains

Understanding VV2369's function may require contextualizing it within known virulence pathways. V. vulnificus pathogenesis involves multiple virulence factors including toxin production (MARTX Vv toxin), capsule formation, and various other mechanisms . Consider investigating VV2369's relationship to these established pathways.

How can I design experiments to elucidate the function of previously uncharacterized proteins like VV2369?

Designing experiments for uncharacterized proteins requires a systematic approach combining bioinformatics and experimental techniques:

Step-by-Step Experimental Design Methodology:

  • Bioinformatic analysis:

    • Perform sequence homology searches across multiple databases

    • Use structural prediction tools (AlphaFold, I-TASSER) to predict 3D structure

    • Identify conserved domains and motifs

    • Analyze genomic context and potential operons

  • Expression pattern analysis:

    • Determine conditions that upregulate VV2369 expression

    • Compare expression across different growth phases, stress conditions, and host-mimicking environments

    • Create promoter-reporter constructs to monitor expression in real-time

  • Generation of mutant strains:

    • Create knockout and overexpression strains

    • Perform comprehensive phenotypic analysis (growth rates, morphology, biofilm formation)

    • Assess virulence in in vitro and in vivo models

  • Protein interaction studies:

    • Perform pulldown assays with tagged VV2369

    • Use bacterial two-hybrid systems to screen for interaction partners

    • Validate interactions using co-immunoprecipitation or FRET

  • Structural and biochemical characterization:

    • Purify sufficient quantities of recombinant protein

    • Perform enzymatic activity screens based on structural predictions

    • Attempt crystallization for structural determination

When designing these experiments, remember that V. vulnificus has been shown to have significant strain-to-strain variation in virulence factors , so consider testing your hypotheses across multiple strains. The pan-genome analysis approach used for comparing virulence and antibiotic resistance profiles across strains could be adapted to understand the role of VV2369.

What is known about the evolutionary conservation of VV2369 across different Vibrio vulnificus strains?

Understanding the evolutionary conservation of VV2369 requires comparative genomic analysis across Vibrio vulnificus strains:

Analysis AspectMethodological ApproachKey Considerations
Sequence conservationMulti-sequence alignment across strainsIdentify conserved domains vs. variable regions
Genomic contextAnalysis of surrounding genesDetermine if VV2369 is part of conserved operons
Strain distributionPresence/absence analysisCorrelate with strain virulence or environmental adaptation
Selective pressuredN/dS ratio analysisIdentify regions under positive or purifying selection

For comprehensive analysis:

  • Compare VV2369 across clinical isolates (such as YJ016, CMCP6) and environmental isolates

  • Consider biotype differences (Biotype 1, 2, and 3 strains show significant genetic differences)

  • Examine correlation with established virulence markers (vcg, 16S rRNA types, vvhA)

  • Analyze strain-specific gene variants as has been done with rtxA1 gene variants

Research with other V. vulnificus genes has shown significant genetic variation between strains. For example, the rtxA1 gene that encodes MARTX Vv toxin has at least four distinct variants with different arrangements of effector domains . Similarly, pan-genome analysis of 26 V. vulnificus strains revealed shared core genes (3,016) and strain-specific genes .

A similar analysis of VV2369 could reveal its conservation pattern and help determine if it belongs to the core genome (present in ≥99% of strains), soft core genome (≥95% and <99%), or accessory genome, providing insights into its evolutionary and functional importance .

What methods can be used to analyze VV2369 interactions with host proteins during infection?

Investigating VV2369 interactions with host proteins requires multiple complementary techniques:

TechniqueApplicationTechnical Considerations
Pull-down assaysIdentify direct binding partnersRequires recombinant VV2369 with affinity tag
Yeast two-hybridScreen for potential interactionsMay generate false positives, requires validation
Biolayer interferometryMeasure binding kineticsRequires purified proteins, provides quantitative data
Crosslinking mass spectrometryIdentify interaction interfacesCan capture transient interactions in native context
Proximity labeling (BioID/APEX)Identify proximal proteins in vivoCan detect weak or transient interactions

Methodological approach for comprehensive interaction analysis:

  • Express tagged VV2369 in V. vulnificus under native control

  • Perform infection studies with human cell lines relevant to infection (e.g., epithelial cells)

  • Crosslink proteins during infection to capture transient interactions

  • Immunoprecipitate VV2369 complexes and identify binding partners by mass spectrometry

  • Validate key interactions using co-immunoprecipitation and functional studies

Considerations specific to V. vulnificus research:

  • Target cell types should include those relevant to pathogenesis (epithelial cells, macrophages)

  • Consider iron-regulated interactions, as iron acquisition is critical for V. vulnificus virulence

  • Examine interactions with components of the host immune system, particularly those involved in serum resistance mechanisms

  • Compare interaction profiles between virulent and attenuated strains to identify pathogenesis-relevant interactions

How can comparative genomics inform our understanding of VV2369's potential role?

Comparative genomics provides powerful insights into the potential function of uncharacterized proteins like VV2369:

Methodological Framework for Comparative Genomic Analysis:

  • Strain Comparison Analysis:

    • Compare VV2369 presence, sequence variation, and genomic context across multiple V. vulnificus strains

    • Correlate sequence variations with strain virulence phenotypes

    • Determine if VV2369 is part of the core genome (≥99% presence), soft core genes (≥95% and <99% presence), or accessory genome

  • Cross-Species Analysis:

    • Identify homologs in other Vibrio species and more distant bacterial taxa

    • Analyze co-evolution with known virulence factors

    • Examine synteny (conservation of gene order) to identify functional relationships

  • Phylogenetic Profiling:

    • Construct phylogenetic trees to understand evolutionary history

    • Correlate presence/absence with specific phenotypes or environmental adaptations

    • Identify instances of horizontal gene transfer

  • Functional Prediction:

    • Analyze co-expression patterns with genes of known function

    • Examine correlation with specific genomic islands associated with virulence

    • Use guilt-by-association approaches to infer function

Analysis TypeToolsExpected Outputs
Whole genome alignmentMauve, RoaryConservation patterns, gene synteny
Pan-genome analysisRoary, OrthoMCLCore/accessory genome classification
Phylogenetic analysisMEGA, RAxMLEvolutionary relationships
Functional predictionSTRING, GeneMANIAPredicted functional partners

Similar pan-genome analysis approaches have been successfully used with V. vulnificus to characterize virulence factors and antibiotic resistance profiles across strains , revealing significant genomic diversity that contributes to pathogenic diversity. Applying these methods to VV2369 could provide crucial insights into its functional role and importance in V. vulnificus biology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.